Avadel Pharmaceuticals plc (NASDAQ:AVDL – Get Free Report) has been assigned an average recommendation of “Buy” from the seven ratings firms that are currently covering the stock, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy recommendation. The average 1 year price target among analysts that have covered the stock in the […]
Avadel Pharmaceuticals (NASDAQ:AVDL – Free Report) had its price target increased by HC Wainwright from $21.00 to $25.00 in a research note issued to investors on Tuesday, MarketBeat Ratings reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Avadel Pharmaceuticals’ Q1 2024 earnings at ($0.31) EPS, Q3 2024 […]
Avadel Pharmaceuticals plc (NASDAQ:AVDL – Get Free Report) was the recipient of some unusual options trading on Tuesday. Traders purchased 5,250 put options on the stock. This represents an increase of approximately 324% compared to the average volume of 1,239 put options. Insider Activity at Avadel Pharmaceuticals In related news, Director Mark Anthony Mccamish sold […]
Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL – Get Free Report) have received a consensus rating of “Buy” from the six research firms that are currently covering the firm, MarketBeat.com reports. Six investment analysts have rated the stock with a buy rating. The average 1-year price target among brokerages that have updated their coverage on the […]
Avadel Pharmaceuticals plc (NASDAQ:AVDL – Free Report) – Investment analysts at Leerink Partnrs lifted their FY2025 earnings per share estimates for shares of Avadel Pharmaceuticals in a research note issued to investors on Monday, January 29th. Leerink Partnrs analyst M. Goodman now expects that the company will earn $1.22 per share for the year, up […]